These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 17459081

  • 21. Botulinum neurotoxin-A for treatment of refractory neck pain: a randomized, double-blind study.
    Miller D, Richardson D, Eisa M, Bajwa RJ, Jabbari B.
    Pain Med; 2009 Sep; 10(6):1012-7. PubMed ID: 19594841
    [Abstract] [Full Text] [Related]

  • 22. Botulinum toxin as a preventive treatment for migraine and chronic tension headache.
    Cattin T.
    N Z Med J; 2003 May 16; 116(1174):U440. PubMed ID: 12766786
    [No Abstract] [Full Text] [Related]

  • 23. A prospective randomized controlled study of the role of botulinum toxin in whiplash-associated disorder.
    Carroll A, Barnes M, Comiskey C.
    Clin Rehabil; 2008 Jun 16; 22(6):513-9. PubMed ID: 18511531
    [Abstract] [Full Text] [Related]

  • 24. Role of botulinum toxin type A in the prophylactic treatment of migraine headaches.
    Chilson CN, Brown SJ.
    Ann Pharmacother; 2005 Dec 16; 39(12):2081-5. PubMed ID: 16264063
    [Abstract] [Full Text] [Related]

  • 25. Botulinum toxin type A in chronic migraine.
    Freitag FG.
    Expert Rev Neurother; 2007 May 16; 7(5):463-70. PubMed ID: 17492897
    [Abstract] [Full Text] [Related]

  • 26. Subcutaneous Botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin.
    Gazerani P, Pedersen NS, Staahl C, Drewes AM, Arendt-Nielsen L.
    Pain; 2009 Jan 16; 141(1-2):60-9. PubMed ID: 19004549
    [Abstract] [Full Text] [Related]

  • 27. OnabotulinumtoxinA (botulinum toxin type-A) in the prevention of migraine.
    Cady RK.
    Expert Opin Biol Ther; 2010 Feb 16; 10(2):289-98. PubMed ID: 20088719
    [Abstract] [Full Text] [Related]

  • 28. Importance of botulinum toxin for prevention of migraine.
    Freitag FG.
    Expert Rev Neurother; 2010 Mar 16; 10(3):339-40. PubMed ID: 20187855
    [No Abstract] [Full Text] [Related]

  • 29. Improvement in quality of life after botulinum toxin-A injections for idiopathic detrusor overactivity: results from a randomized double-blind placebo-controlled trial.
    Sahai A, Dowson C, Khan MS, Dasgupta P.
    BJU Int; 2009 Jun 16; 103(11):1509-15. PubMed ID: 19389019
    [Abstract] [Full Text] [Related]

  • 30. Two-year placebo-controlled trial of botulinum toxin A for leg spasticity in cerebral palsy.
    Moore AP, Ade-Hall RA, Smith CT, Rosenbloom L, Walsh HP, Mohamed K, Williamson PR.
    Neurology; 2008 Jul 08; 71(2):122-8. PubMed ID: 18606966
    [Abstract] [Full Text] [Related]

  • 31. Placebo efficacy in childhood and adolescence migraine: an analysis of double-blind and placebo-controlled studies.
    Evers S, Marziniak M, Frese A, Gralow I.
    Cephalalgia; 2009 Apr 08; 29(4):436-44. PubMed ID: 19170687
    [Abstract] [Full Text] [Related]

  • 32. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study.
    Landau CJ, Carr WD, Razzetti AJ, Sessler NE, Munera C, Ripa SR.
    Clin Ther; 2007 Oct 08; 29(10):2179-93. PubMed ID: 18042474
    [Abstract] [Full Text] [Related]

  • 33. The analgesic effect of botulinum-toxin A on postwhiplash neck pain.
    Braker C, Yariv S, Adler R, Badarny S, Eisenberg E.
    Clin J Pain; 2008 Jan 08; 24(1):5-10. PubMed ID: 18180629
    [Abstract] [Full Text] [Related]

  • 34. Predictors of migraine headache recurrence: a pooled analysis from the eletriptan database.
    Dodick DW, Lipton RB, Goadsby PJ, Tfelt-Hansen P, Ferrari MD, Diener HC, Almas M, Albert KS, Parsons B.
    Headache; 2008 Feb 08; 48(2):184-93. PubMed ID: 18234045
    [Abstract] [Full Text] [Related]

  • 35. Single-dose intravenous tramadol for acute migraine pain in adults: a single-blind, prospective, randomized, placebo-controlled clinical trial.
    Alemdar M, Pekdemir M, Selekler HM.
    Clin Ther; 2007 Jul 08; 29(7):1441-7. PubMed ID: 17825695
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Botulinum toxin a in the treatment of chronic tension-type headache with cervical myofascial trigger points: a randomized, double-blind, placebo-controlled pilot study.
    Harden RN, Cottrill J, Gagnon CM, Smitherman TA, Weinland SR, Tann B, Joseph P, Lee TS, Houle TT.
    Headache; 2009 May 08; 49(5):732-43. PubMed ID: 19178577
    [Abstract] [Full Text] [Related]

  • 38. Botulinum toxin type A for migraine. First, do no harm.
    Prescrire Int; 2011 Dec 08; 20(122):287-90. PubMed ID: 22216539
    [Abstract] [Full Text] [Related]

  • 39. Therapeutic use of botulinum toxin type A in treating neck and upper-back pain of myofascial origin: a pilot study.
    Lew HL, Lee EH, Castaneda A, Klima R, Date E.
    Arch Phys Med Rehabil; 2008 Jan 08; 89(1):75-80. PubMed ID: 18164334
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.